Apnimed to Present at the Jefferies Healthcare Conference

CAMBRIDGE, Mass. June 6, 2022 – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced that Apnimed will participate in the Jefferies...